Studies that assessed the effects of exercise on persons with metastatic, advanced or palliative cancer were eligible for inclusion. Excluded studies were: studies of persons with lymphoma, melanoma or myeloma; studies where results of patients with metastatic cancer could not be separated from those with non-metastatic cancer; and newspaper editorials, critical reviews of individual articles and qualitative research studies. Studies were excluded if less than one-third of the sample had metastatic or advanced cancer. The terms used and stages of cancer were defined.
The baseline characteristics with respect to age, primary cancer site or type, cancer status, interventions, comorbidities and health status varied across the studies. Three of the studies included only persons with metastatic cancer. Five studies included samples in which 39% to 80% of the participants were described as having advanced or metastatic cancer or receiving treatment with palliative intent. An intervention could be solely exercise or exercise could be a component of the intervention. Types of exercise were aerobic and muscle strengthening and varied in type, frequency and intensity. All studies used physical and/or quality-of-life outcome measures. The tools used for measuring outcomes varied across studies.
Two independent reviewers screened titles, abstracts and full texts. Disagreements were resolved by consensus. Arbitration by a third reviewer was used for unresolved disagreements.